Limited coverage criteria – risedronate

Last updated on March 19, 2025

 

Return to Special Authority drug list

Generic name

risedronate

Strength & form

30mg tablet

Special Authority criteria

Approval period

Diagnosis of Paget's disease

Indefinite

Practitioner exemptions

  • None

Special notes

  • None

Special Authority request form(s)